36605456|t|The influence of LPL S447X variants and obesity on lipid profile, oxidative stress, and the risk of T2DM: A case-control study.
36605456|a|Aims: The present study aimed to investigate the association between lipoprotein lipase (LPL) S447X polymorphism and type 2 diabetes mellitus (T2DM), obesity, lipid profile, and oxidative stress parameters in a population from the Kurdistan region of Iraq. Method: We studied 250 adults (51% female and 49% male) aged 45-65 years in four groups, obese and normal body mass index (BMI) diabetic patients versus healthy normal BMI and obese individuals as controls. Lipid profile and oxidative stress parameters were analyzed by colorimetric assay. The LPL S447X genotypes were detected by polymerase chain reaction (PCR)-restriction fragment length polymorphism. Results: We found that the obese diabetic group had higher levels of triglycerides (TG), cholesterol, and low-density lipoprotein-cholesterol, and lower level of high-density lipoprotein-cholesterol than other groups. Obese diabetic patients had higher anthropometric indices than nonobese diabetic patients, obese and normal BMI controls. The levels of TG and total oxidative status (TOS) were significantly lower and higher, respectively, in normal BMI controls than in obese controls. Obese diabetic patients had a lower level of total antioxidant capacity than nondiabetic obese controls. The level of TOS was lower in nondiabetic controls compared to the patient groups. Obese diabetic patients had the highest TOS and malondialdehyde levels. The LPL SX genotype was associated with decreased the risk of T2DM by 79% (odds ratio [OR] = 0.21; 95% confidence interval [CI]: 0.05-0.81, p = 0.03). Also, the presence of this genotype reduced the risk of obesity by 39% (OR = 0.61; 95% CI: 0.07-4.90, p = 0.6). In all individuals, the presence of the SX genotype was associated with significantly lower levels of fasting blood sugar (FBS) and TOS. Conclusion: We report the influence of obesity on lipid profile in diabetic and nondiabetic individuals and the effect of LPL SX genotype on decreased risk of T2DM and reduced levels of FBS and TOS.
36605456	17	20	LPL	Gene	4023
36605456	21	26	S447X	ProteinMutation	tmVar:p|SUB|S|447|X;HGVS:p.S447X;VariantGroup:0;CorrespondingGene:4023;RS#:328;CorrespondingSpecies:9606;CA#:115037
36605456	40	47	obesity	Disease	MESH:D009765
36605456	51	56	lipid	Chemical	MESH:D008055
36605456	100	104	T2DM	Disease	MESH:D003924
36605456	197	215	lipoprotein lipase	Gene	4023
36605456	217	220	LPL	Gene	4023
36605456	222	227	S447X	ProteinMutation	tmVar:p|SUB|S|447|X;HGVS:p.S447X;VariantGroup:0;CorrespondingGene:4023;RS#:328;CorrespondingSpecies:9606;CA#:115037
36605456	245	269	type 2 diabetes mellitus	Disease	MESH:D003924
36605456	271	275	T2DM	Disease	MESH:D003924
36605456	278	285	obesity	Disease	MESH:D009765
36605456	287	292	lipid	Chemical	MESH:D008055
36605456	474	479	obese	Disease	MESH:D009765
36605456	513	521	diabetic	Disease	MESH:D003920
36605456	522	530	patients	Species	9606
36605456	561	566	obese	Disease	MESH:D009765
36605456	592	597	Lipid	Chemical	MESH:D008055
36605456	679	682	LPL	Gene	4023
36605456	683	688	S447X	ProteinMutation	tmVar:p|SUB|S|447|X;HGVS:p.S447X;VariantGroup:0;CorrespondingGene:4023;RS#:328;CorrespondingSpecies:9606;CA#:115037
36605456	817	831	obese diabetic	Disease	MESH:D009765
36605456	859	872	triglycerides	Chemical	MESH:D014280
36605456	874	876	TG	Chemical	MESH:D014280
36605456	879	890	cholesterol	Chemical	MESH:D002784
36605456	1008	1022	Obese diabetic	Disease	MESH:D009765
36605456	1023	1031	patients	Species	9606
36605456	1080	1088	diabetic	Disease	MESH:D003920
36605456	1089	1097	patients	Species	9606
36605456	1099	1104	obese	Disease	MESH:D009765
36605456	1144	1146	TG	Chemical	MESH:D014280
36605456	1262	1267	obese	Disease	MESH:D009765
36605456	1278	1292	Obese diabetic	Disease	MESH:D009765
36605456	1293	1301	patients	Species	9606
36605456	1367	1372	obese	Disease	MESH:D009765
36605456	1450	1457	patient	Species	9606
36605456	1466	1480	Obese diabetic	Disease	MESH:D009765
36605456	1481	1489	patients	Species	9606
36605456	1514	1529	malondialdehyde	Chemical	MESH:D008315
36605456	1542	1545	LPL	Gene	4023
36605456	1600	1604	T2DM	Disease	MESH:D003924
36605456	1745	1752	obesity	Disease	MESH:D009765
36605456	1911	1922	blood sugar	Chemical	MESH:D001786
36605456	1977	1984	obesity	Disease	MESH:D009765
36605456	1988	1993	lipid	Chemical	MESH:D008055
36605456	2005	2013	diabetic	Disease	MESH:D003920
36605456	2060	2063	LPL	Gene	4023
36605456	2097	2101	T2DM	Disease	MESH:D003924
36605456	Association	MESH:D014280	RS#:328;HGVS:p.S447X;CorrespondingGene:4023
36605456	Association	MESH:D003924	RS#:328;HGVS:p.S447X;CorrespondingGene:4023
36605456	Association	MESH:D008055	RS#:328;HGVS:p.S447X;CorrespondingGene:4023
36605456	Association	MESH:D009765	RS#:328;HGVS:p.S447X;CorrespondingGene:4023
36605456	Positive_Correlation	MESH:D008315	MESH:D009765
36605456	Association	MESH:D001786	4023
36605456	Association	MESH:D014280	4023
36605456	Positive_Correlation	MESH:D002784	MESH:D009765
36605456	Association	MESH:D008055	MESH:D003920
36605456	Association	MESH:D008055	4023
36605456	Positive_Correlation	MESH:D014280	MESH:D009765
36605456	Association	MESH:D003924	4023
36605456	Association	MESH:D009765	4023
36605456	Association	MESH:D003924	4023
36605456	Association	MESH:D009765	4023

